Christopher Gibson - Net Worth and Insider Trading

Christopher Gibson Net Worth

The estimated net worth of Christopher Gibson is at least $6 Million dollars as of 2025-04-30. Christopher Gibson is the CEO of Recursion Pharmaceuticals Inc and owns about 1,117,450 shares of Recursion Pharmaceuticals Inc (RXRX) stock worth over $6 Million. Details can be seen in Christopher Gibson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Gibson has not made any transactions after 2025-03-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Christopher Gibson

To

Christopher Gibson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Gibson owns 1 companies in total, including Recursion Pharmaceuticals Inc (RXRX) .

Click here to see the complete history of Christopher Gibson’s form 4 insider trades.

Insider Ownership Summary of Christopher Gibson

Ticker Company Transaction Date Type of Owner
RXRX Recursion Pharmaceuticals Inc 2025-03-27 director & 10 percent owner & Chief Executive Officer

Christopher Gibson Latest Holdings Summary

Christopher Gibson currently owns a total of 1 stock. Christopher Gibson owns 1,117,450 shares of Recursion Pharmaceuticals Inc (RXRX) as of March 27, 2025, with a value of $6 Million.

Latest Holdings of Christopher Gibson

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RXRX Recursion Pharmaceuticals Inc 2025-03-27 1,117,450 5.72 6,391,814

Holding Weightings of Christopher Gibson


Christopher Gibson Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Gibson has made a total of 55 transactions in Recursion Pharmaceuticals Inc (RXRX) over the past 5 years, including 0 buys and 55 sells. The most-recent trade in Recursion Pharmaceuticals Inc is the sale of 138,574 shares on March 27, 2025, which brought Christopher Gibson around $836,987.

Insider Trading History of Christopher Gibson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Gibson Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Gibson Ownership Network

Ownership Network List of Christopher Gibson

No Data

Ownership Network Relation of Christopher Gibson

Insider Network Chart

Christopher Gibson Owned Company Details

What does Recursion Pharmaceuticals Inc do?

Who are the key executives at Recursion Pharmaceuticals Inc?

Christopher Gibson is the director & 10 percent owner & Chief Executive Officer of Recursion Pharmaceuticals Inc. Other key executives at Recursion Pharmaceuticals Inc include Chief Financial Officer Michael Secora , President and COO Tina Marriott Larson , and Chief Corp. Dev. Officer Shafique Virani .

Recursion Pharmaceuticals Inc (RXRX) Insider Trades Summary

Over the past 18 months, Christopher Gibson made 19 insider transaction in Recursion Pharmaceuticals Inc (RXRX) with a net sale of 1,251,024. Other recent insider transactions involving Recursion Pharmaceuticals Inc (RXRX) include a net sale of 375,641 shares made by Blake Borgeson , a net sale of 478,124 shares made by Michael Secora , and a net sale of 71,000 shares made by Tina Marriott Larson .

In summary, during the past 3 months, insiders sold 218,574 shares of Recursion Pharmaceuticals Inc (RXRX) in total and bought 0 shares, with a net sale of 218,574 shares. During the past 18 months, 2,278,930 shares of Recursion Pharmaceuticals Inc (RXRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,278,930 shares.

Recursion Pharmaceuticals Inc (RXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Recursion Pharmaceuticals Inc Insider Transactions

No Available Data

Christopher Gibson Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Gibson. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Christopher Gibson's mailing address is: Salt Lake City Ut 84101.